Accessibility StatementSkip Navigation RADNOR, Pa., Sept. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLPÂ (www.ktmc.com) Â informs investors that a securities class action lawsuit has been filed against Dow Inc. ("Dow") (NYSE: DOW) on behalf of those who purchased or otherwise acquired Dow securities between January 30, 2025, and July 23, 2025, inclusive (the "Class Period"). The lead plaintiff deadline is October 28, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:Â Â Â Â If y ...

Core Viewpoint - A class action securities lawsuit has been filed against RxSight, Inc. due to alleged securities fraud affecting investors between November 7, 2024, and July 8, 2025 [1][2] Group 1: Allegations - The lawsuit claims that RxSight, Inc. faced "adoption challenges" and structural issues leading to declines in sales and utilization [2] - It is alleged that the defendants overstated the demand for RxSight's products [2] - The company is unlikely to meet its previously issued financial guidance for fiscal year 2025 due to these issues [2] - Positive statements made by the defendants regarding the company's business and prospects were materially misleading and lacked a reasonable basis [2] Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until September 22, 2025, to request to be appointed as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the U.S. [4]

Core Viewpoint - A class action securities lawsuit has been filed against Lantheus Holdings, Inc. for alleged securities fraud affecting investors between February 26, 2025, and August 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Lantheus made false statements and concealed information regarding its revenue outlook and growth potential, particularly related to the sales growth of its product Pylarify [2]. - The complaint alleges that Lantheus misrepresented its understanding of market dynamics, including competition and pricing, leading to an inaccurate portrayal of its financial health [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until November 10, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, highlighting its expertise in complex securities cases [4].

Core Viewpoint - C3.ai, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 26, 2025, and August 8, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that C3.ai's management provided misleading positive statements while concealing adverse facts about the company's growth, particularly regarding the health of its CEO and its impact on deal closures [2] - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [2] - Following the announcement, C3.ai's stock price dropped from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [2] Group 2: Next Steps for Investors - Investors who suffered losses in C3.ai during the relevant period have until October 21, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [2]. - As a result of these actions, the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Next Steps for Investors - Investors who experienced losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be eligible for compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4].

Core Viewpoint - The Law Offices of Frank R. Cruz is reminding investors about the September 22, 2025 deadline to participate as a lead plaintiff in a securities fraud class action lawsuit against RxSight, Inc. for investors who acquired its securities during the specified class period [1] Group 1 - The class action lawsuit is on behalf of investors who purchased RxSight, Inc. securities between May 7, 2024, and July 8, 2025 [1] - Investors who lost money on RxSight, Inc. are encouraged to participate in the securities fraud lawsuit [1]

PHILADELPHIA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is investigating the proposed buyout of WideOpenWest, Inc. (NYSE: WOW) shareholders to determine whether the transaction as structured is fair to the company’s investors and provides investors with sufficient compensation for their shares.  Click here to submit your information to the firm: https://kaskelalaw.com/case/wideopenwest/    On August 11, 2025, WideOpenWest announced that it had agreed to be acquire ...

Core Viewpoint - Semler Scientific, Inc. is facing a securities fraud class action lawsuit due to alleged misleading statements regarding a Department of Justice investigation into the company's reimbursement claims related to the QuantaFlo device [3][5]. Group 1: Company Background and Events - On February 28, 2025, Semler disclosed in its Form 10-K that it received a civil investigative demand from the DOJ in July 2017 concerning its reimbursement claims [3]. - Following unsuccessful settlement discussions with the DOJ in February 2025, Semler's share price fell by approximately 9.39%, from $42.92 to $38.89 [3]. - On April 15, 2025, Semler announced a settlement agreement of $29.75 million to resolve all claims, leading to a further decline in share price by about 9.9%, from $34.40 to $31.00 [4]. Group 2: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased Semler securities from March 10, 2021, to April 15, 2025, alleging that the company made false or misleading statements regarding the DOJ investigation [5]. - The lawsuit claims that the company failed to disclose material information about the investigation, which resulted in investor damages when the truth was revealed [5].

Core Points - RCI Hospitality Holdings, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices [1] - New York's Office of the Attorney General indicted certain top executives of RCI, alleging bribery of an auditor to avoid over $8 million in sales taxes from 2010 to 2024 [3] - Following the indictment news, RCI's share price dropped by $5.53, approximately 16.11%, from $34.32 to $28.79 [3] Company Overview - RCI Hospitality Holdings, Inc. trades on NASDAQ under the ticker RICK [1] - The company is facing serious legal challenges that could impact its financial standing and reputation [1][3] Legal Context - The investigation is being conducted by Kirby McInerney LLP, a law firm specializing in securities litigation [1][6] - The firm has a history of recovering billions of dollars for shareholders in similar cases [6]

Core Viewpoint - Investors in C3.ai, Inc. have the opportunity to lead a securities fraud class action lawsuit due to alleged misleading statements regarding the company's growth and the health of its CEO [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit claims that from February 26, 2025, to August 8, 2025, C3.ai's management failed to disclose critical information, including the over-reliance on the CEO's health and effectiveness [2]. - Allegations include that the optimistic reports on growth, earnings potential, and margins were not reflective of the actual situation, as the CEO had not sufficiently recovered to fulfill his role [2]. Participation Information - Investors who suffered losses related to C3.ai are encouraged to participate in the lawsuit before the lead plaintiff deadline of October 21, 2025 [2]. - Interested parties can contact The Law Offices of Frank R. Cruz for more information or to participate in the class action [3][4].